Author:
Maran A.,Shogren K.,Zhang M.,Yaszemski M.J.,Hefferan T.E.,Spelsberg T.C.,Kloosterboer H.J.,Turner R.T.
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference36 articles.
1. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies;Gallagher;J. Clin. Endocrinol. Metab.,2001
2. 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor;Reed;Biochem. Biophys. Res. Commun.,2004
3. Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments;Kloosterboer;J. Steroid. Biochem. Mol. Biol.,2002
4. Tibolone: a compound with tissue specific inhibitory effects on sulfatase;de Gooyer;Mol. Cell. Endocrinol.,2001
5. Effect of a standardized meal on the bioavailability of a single oral dose of tibolone 2.5 mg in healthy postmenopausal women;Timmer;Pharmacotherapy,2002
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献